Tharick A Pascoal

Targets

• APOE 2

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy data.

  Brain : a journal of neurology, Aug 2026

• Publication

  Streamlined resource-efficient plasma amyloid-beta mass spectrometry assay has improved biomarker performance in preclinical Alzheimer's disease.

  Nature communications, Jan 2026

• Publication

  In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer's disease continuum.

  Molecular psychiatry, Dec 2025

• Publication

  Impact of cardiometabolic factors and AD plasma biomarkers on white matter hyperintensities volume in individuals with cognitive complaints from the global south.

  Neuroscience, Dec 2025

• Publication

  Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials.

  Neurology, Dec 2025

• Publication

  Biomarkers.

  Alzheimer's & dementia : the journal of the Alzheimer's Association, Dec 2025

• Publication

  APOE ɛ4 carriership determines a faster plasma p-tau217 progression in Aβ-positive individuals.

  Alzheimer's & dementia : the journal of the Alzheimer's Association, Dec 2025

• Publication

  APOE ε4 potentiates tau related reactive astrogliosis assessed by cerebrospinal fluid YKL40 in Alzheimer's disease.

  Communications medicine, Nov 2025

• Publication

  Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer's disease.

  Nature neuroscience, Nov 2025

Affiliations

• University of Pittsburgh

Co-authors

• DLDouglas T LeffaHow are we linked?
• EZEduardo R ZimmerHow are we linked?
• MWMarcel S WooHow are we linked?

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.